Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001387131-18-005451

CEO sold 184,000 shares at an average $5.55 ($1,020,832)

  • CEO acquired 184,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Finizio Robert G CEO 2018-10-11 Option exercise +92,000 $0.10 $9,366 18,485,559 D: show line 1 in the form
Finizio Robert G CEO 2018-10-11 Sale −92,000 $5.65 $519,616 18,393,559 D: show line 2 in the form
Finizio Robert G CEO 2018-10-12 Option exercise +92,000 $0.10 $9,366 18,485,559 D: show line 3 in the form
Finizio Robert G CEO 2018-10-12 Sale −92,000 $5.45 $501,216 18,393,559 D: show line 4 in the form
Open-market sales · 184,000 sh · avg $5.55 · $1,020,832

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Finizio Robert G CEO 2018-10-11 Option exercise · Non-Qualified Stock Option (right to buy) −92,000 1,012,910 D: show line 5 in the form
Finizio Robert G CEO 2018-10-12 Option exercise · Non-Qualified Stock Option (right to buy) −92,000 920,910 D: show line 6 in the form
Loading xslF345X03/finizio-form4_101118.xml…